A A A Text Size
E-mail E-mail This Page
 

News

Fox Chase Cancer Center's Radiation Oncology Staff Adds Lally

PHILADELPHIA (August 5, 2008)—Brian E. Lally, MD, of Wyncote, PA, has joined Fox Chase Cancer Center's radiation oncology department.  A board-certified radiation oncologist, he specializes in treating patients with lung cancer and other chest tumors such as esophageal cancer. 

He has a special interest in translational research—research that translates laboratory research discoveries into clinical advances.  He is also exploring the use of agents to make brain tumors more sensitive to radiation therapy.

"I am interested in combining novel agents with chemotherapy and radiation to improve cancer outcomes," Lally explained.  "I am also interested in using imaging techniques, such as PET scans, to better understand how much radiation tumors receive during radiation therapy."
Lally has published a number of professional journal papers and made presentations at meetings of the American Society of Therapeutic Radiology and Oncology and other professional organizations.

Lally received his bachelor's and master’s degrees in bioengineering from the University of Pennsylvania and his medical degree from Thomas Jefferson University in Philadelphia.  After interning in medicine at Geisinger Medical Center in Danville, PA, he served his residency in radiation oncology and was chief resident at Yale University School of Medicine – New Haven Hospital in New Haven, CT.

He then held a fellowship in translational radiation oncology at Wake Forest University School of Medicine in Winston-Salem, NC, before joining Fox Chase.


Fox Chase Cancer Center is one of the leading freestanding cancer research and treatments centers in the United States. Founded in 1904 in Philadelphia as the nation's first cancer hospital, Fox Chase became one of the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, treatment, and community outreach. For more information, call 1-888-FOX-CHASE or 1-888-369-2427. Other 2008 releases

Media inquiries only, please contact Frank Hoke at 215-728-2700 or Diana Quattrone at 215-728-7784.